Investec amends Advanced Medical Solutions share-dealing disclosure

  • Investec amended its Rule 8.5 disclosure for Advanced Medical Solutions ordinary shares.
  • Investec bought 35,703 shares and sold 515,471 shares on September 18, 2026.
  • Canaccord disclosed a 4.1526% interest, while both filings reported no derivatives or related arrangements.

Canaccord Genuity Wealth Limited, acting for discretionary clients, disclosed a 4.1526% interest in Advanced Medical Solutions Group PLC under Rule 8.3 of the Takeover Code, comprising 9,169,681 5p ordinary shares after selling 8,390 shares at 281.5 pence and 26,135 at 281.55 pence on September 18, 2026. Separately, an amended Form 8.5 filing from Investec Bank Plc, an exempt principal trader with recognised intermediary status and Advanced Medical Solutions’ advisor and joint broker, reported purchases of 35,703 ordinary shares and sales of 515,471 shares on the same date. Both types of dealing were reported within a range of 281.5 pence to 282 pence per share. Investec reported no derivatives, other dealings, indemnity arrangements, options or related agreements. The amended figures replace the previously recorded Investec totals of 342,106 purchases and 70,097 sales.

The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.